✦ LIBER ✦

PRS15 Estimating the Budget Impact of Introducing Indacaterol in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) from the Brazilian Public Health Care System (SUS) Perspective

✍ Scribed by Suzuki, C.; Silva, N.L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PRS14 Estimating the Budget Impact of In

✍ Suzuki, C.; Silva, N.L. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PRS31 Economic Evaluation of Indacaterol

✍ Suzuki, C.; Silva, N.L. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PRS22 Cost-Effectiveness of Indacaterol

✍ A. Reyes-lopez; E.A. Lemus-carmona; E. Orozco 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

A Budget Impact Analysis (BIA) of Transc

✍ Paladini, L.; Nishikawa, A.M.; Bueno, C.C.; Queiroga, M.; Lemos, P.; Clark, O.A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PMS20 COST-EFFECTIVENESS AND BUDGET IMPA

✍ Fernandes, RA; Quintella, FF; Teich, V; Carvalho, JCN; Molinari, MB; Krambek, MC 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB